Phase 1 Aneurysm Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

Delayed Cerebral IschemiaAneurysmal Subarachnoid Hemorrhage

University of Florida30 enrolled1 locationNCT06863480

Recruiting

Phase 1

Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

Thoracoabdominal Aortic AneurysmComplex Aortic AneurysmsEndovascular Repair

Peking Union Medical College Hospital60 enrolled11 locationsNCT07141251

Recruiting

Phase 1Phase 2

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

StrokeVasculitisAneurysm+1 more

University of California, San Francisco8 enrolled1 locationNCT02638701

Completed

Phase 1

Comparison of two drug thinning agents (unfractionated heparin and low-molecular weight heparin) for prevention of stroke after brain aneurysm treatment utilizing coils or stents

Intracranial LesionsIntracranial Aneurysm

Royal Brisbane and Women's Hospital75 enrolled1 locationACTRN12616001277437